{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:41:14Z","timestamp":1792651274062,"version":"4.5.0"},"reference-count":99,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Immunology"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.coi.2021.07.001","type":"journal-article","created":{"date-parts":[[2021,7,24]],"date-time":"2021-07-24T03:59:15Z","timestamp":1627099155000},"page":"262-271","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"special_numbering":"C","title":["Mycobacterial diseases in patients with inborn errors of immunity"],"prefix":"10.1016","volume":"72","author":[{"given":"St\u00e9phanie","family":"Boisson-Dupuis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacinta","family":"Bustamante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coi.2021.07.001_bib0005","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1146\/annurev.immunol.20.081501.125851","article-title":"Genetic dissection of immunity to mycobacteria: the human model","volume":"20","author":"Casanova","year":"2002","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.coi.2021.07.001_bib0010","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1126\/science.284.5419.1520","article-title":"Comparative genomics of BCG vaccines by whole-genome DNA microarray","volume":"284","author":"Behr","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.coi.2021.07.001_bib0015","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/imr.12272","article-title":"Inherited and acquired immunodeficiencies underlying tuberculosis in childhood","volume":"264","author":"Boisson-Dupuis","year":"2015","journal-title":"Immunol Rev"},{"key":"10.1016\/j.coi.2021.07.001_bib0020","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1017\/S0950268897007917","article-title":"The natural history of tuberculosis: the implications of age-dependent risks of disease and the role of reinfection","volume":"119","author":"Vynnycky","year":"1997","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.coi.2021.07.001_bib0025","doi-asserted-by":"crossref","first-page":"e64","DOI":"10.1016\/S1473-3099(17)30623-0","article-title":"Genetics of human susceptibility to active and latent tuberculosis: present knowledge and future perspectives","volume":"18","author":"Abel","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.coi.2021.07.001_bib0030","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00439-008-0474-z","article-title":"Leprosy as a genetic model for susceptibility to common infectious diseases","volume":"123","author":"Alter","year":"2008","journal-title":"Hum Genet"},{"key":"10.1016\/j.coi.2021.07.001_bib0035","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S1473-3099(06)70464-9","article-title":"Mycobacterium ulcerans infection: control, diagnosis, and treatment","volume":"6","author":"Sizaire","year":"2006","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.coi.2021.07.001_bib0040","doi-asserted-by":"crossref","first-page":"E7128","DOI":"10.1073\/pnas.1521651112","article-title":"Severe infectious diseases of childhood as monogenic inborn errors of immunity","volume":"112","author":"Casanova","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coi.2021.07.001_bib0045","doi-asserted-by":"crossref","first-page":"E7118","DOI":"10.1073\/pnas.1521644112","article-title":"Human genetic basis of interindividual variability in the course of infection","volume":"112","author":"Casanova","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coi.2021.07.001_bib0050","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10875-020-00763-0","article-title":"Human inborn errors of immunity: 2019 update on the classification from the International Union of Immunological Societies Expert committee (vol 13, pg 1241, 2020)","volume":"40","author":"Tangye","year":"2020","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.coi.2021.07.001_sbref0055","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1007\/s10875-021-00980-1","article-title":"The ever-increasing array of novel inborn errors of immunity: an interim update by the IUIS committee","volume":"41","author":"Tangye","year":"2021","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.coi.2021.07.001_bib0060","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.jaci.2014.02.028","article-title":"BCG vaccination in patients with severe combined immunodeficiency: complications, risks, and vaccination policies","volume":"133","author":"Marciano","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2021.07.001_bib0065","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1080\/23744235.2019.1628354","article-title":"Bacille Calmette-Guerin (BCG) complications in children with severe combined immunodeficiency (SCID)","volume":"51","author":"Barkai","year":"2019","journal-title":"Infect Dis"},{"key":"10.1016\/j.coi.2021.07.001_bib0070","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.clim.2017.07.007","article-title":"Cernunnos deficiency associated with BCG adenitis and autoimmunity: first case from the national Iranian registry and review of the literature","volume":"183","author":"Yazdani","year":"2017","journal-title":"Clin Immunol"},{"key":"10.1016\/j.coi.2021.07.001_bib0075","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s10875-010-9489-z","article-title":"Molecular diagnosis of severe combined immunodeficiency-identification of IL2RG, JAK3, IL7R, DCLRE1C, RAG1, and RAG2 mutations in a cohort of Chinese and southeast Asian children","volume":"31","author":"Lee","year":"2011","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.coi.2021.07.001_bib0080","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s10875-019-00709-1","article-title":"BCG Moreau vaccine safety profile and NK cells-double protection against disseminated BCG infection in retrospective study of BCG vaccination in 52 polish children with severe combined immunodeficiency","volume":"40","author":"Bernatowska","year":"2020","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.coi.2021.07.001_bib0085","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1128\/jcm.21.2.168-173.1985","article-title":"Infections caused by Mycobacterium avium complex in immunocompromised patients: diagnosis by blood culture and fecal examination, antimicrobial susceptibility tests, and morphological and seroagglutination characteristics","volume":"21","author":"Kiehn","year":"1985","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.coi.2021.07.001_bib0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2019.108321","article-title":"Morbidity in an adenosine deaminase-deficient patient during 27 years of enzyme replacement therapy","volume":"211","author":"Grunebaum","year":"2020","journal-title":"Clin Immunol"},{"key":"10.1016\/j.coi.2021.07.001_bib0095","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1080\/20477724.2020.1725330","article-title":"Nontuberculous mycobacterial infections in a Brazilian pediatric population: a seven-year survey","volume":"114","author":"Mauch","year":"2020","journal-title":"Pathog Glob Health"},{"key":"10.1016\/j.coi.2021.07.001_bib0100","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1093\/clinids\/21.5.1325","article-title":"Disseminated Mycobacterium marinum infection and bacteremia in a child with severe combined immunodeficiency","volume":"21","author":"Parent","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.coi.2021.07.001_bib0105","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1002\/(SICI)1099-0496(199711)24:5<324::AID-PPUL4>3.0.CO;2-I","article-title":"Pulmonary diseases in children with severe combined immune deficiency and DiGeorge syndrome","volume":"24","author":"Deerojanawong","year":"1997","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.coi.2021.07.001_bib0110","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1186\/s12879-020-05421-9","article-title":"Hemophagocytic syndrome associated with Mycobacterium bovis in a patient with X-SCID: a case report","volume":"20","author":"Shi","year":"2020","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.coi.2021.07.001_bib0115","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1182\/blood-2010-06-292490","article-title":"First use of thymus transplantation therapy for FOXN1 deficiency (nude\/SCID): a report of 2 cases","volume":"117","author":"Markert","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.coi.2021.07.001_sbref0120","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1016\/j.jaci.2019.02.014","article-title":"F-BAR domain only protein 1 (FCHO1) deficiency is a novel cause of combined immune deficiency in human subjects","volume":"143","author":"Calzoni","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2021.07.001_bib0125","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.jaci.2015.06.049","article-title":"A novel mutation in the POLE2 gene causing combined immunodeficiency","volume":"137","author":"Frugoni","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2021.07.001_bib0130","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/j.jaci.2018.08.013","article-title":"Hypomorphic caspase activation and recruitment domain 11 (CARD11) mutations associated with diverse immunologic phenotypes with or without atopic disease","volume":"143","author":"Dorjbal","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2021.07.001_bib0135","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.jaci.2019.05.003","article-title":"Combined immunodeficiency in a patient with c-Rel deficiency","volume":"144","author":"Beaussant-Cohen","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2021.07.001_bib0140","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1084\/jem.20060085","article-title":"X-linked susceptibility to mycobacteria is caused by mutations in NEMO impairing CD40-dependent IL-12 production","volume":"203","author":"Filipe-Santos","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2021.07.001_bib0145","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2019.00353","article-title":"Inborn errors of immunity with immune dysregulation: from bench to bedside","volume":"7","author":"Delmonte","year":"2019","journal-title":"Front Pediatr"},{"key":"10.1016\/j.coi.2021.07.001_sbref0150","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1007\/s10875-020-00847-x","article-title":"Human STAT1 gain-of-function heterozygous mutations: chronic mucocutaneous candidiasis and type I interferonopathy","volume":"40","author":"Okada","year":"2020","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.coi.2021.07.001_bib0155","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1182\/blood-2015-11-679902","article-title":"Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype","volume":"127","author":"Toubiana","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.coi.2021.07.001_bib0160","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1084\/jem.20110958","article-title":"Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis","volume":"208","author":"Liu","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2021.07.001_bib0165","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1007\/s00439-020-02120-y","article-title":"Mendelian susceptibility to mycobacterial disease: recent discoveries","volume":"139","author":"Bustamante","year":"2020","journal-title":"Hum Genet"},{"key":"10.1016\/j.coi.2021.07.001_bib0170","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s00439-020-02126-6","article-title":"The monogenic basis of human tuberculosis","volume":"139","author":"Boisson-Dupuis","year":"2020","journal-title":"Hum Genet"},{"key":"10.1016\/j.coi.2021.07.001_bib0175","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1182\/blood-2014-09-602763","article-title":"Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations","volume":"125","author":"Milner","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.coi.2021.07.001_bib0180","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1182\/blood-2014-04-570101","article-title":"Autoimmunity, hypogammaglobulinemia, lymphoproliferation, and mycobacterial disease in patients with activating mutations in STAT3","volume":"125","author":"Haapaniemi","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.coi.2021.07.001_bib0185","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1073\/pnas.1813582116","article-title":"Human RIPK1 deficiency causes combined immunodeficiency and inflammatory bowel diseases","volume":"116","author":"Li","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coi.2021.07.001_sbref0190","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1126\/science.aar2641","article-title":"Biallelic RIPK1 mutations in humans cause severe immunodeficiency, arthritis, and intestinal inflammation","volume":"361","author":"Cuchet-Lourenco","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.coi.2021.07.001_bib0195","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.3389\/fimmu.2018.01103","article-title":"Inherited immunodeficiencies with high predisposition to Epstein-Barr virus-driven lymphoproliferative diseases","volume":"9","author":"Latour","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.coi.2021.07.001_bib0200","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1084\/jem.20160576","article-title":"Dual T cell- and B cell-intrinsic deficiency in humans with biallelic RLTPR mutations","volume":"213","author":"Wang","year":"2016","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2021.07.001_bib0205","doi-asserted-by":"crossref","first-page":"884","DOI":"10.3389\/fimmu.2020.00884","article-title":"A novel pathogenic variant in CARMIL2 (RLTPR) causing CARMIL2 deficiency and EBV-associated smooth muscle tumors","volume":"11","author":"Yonkof","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.coi.2021.07.001_bib0210","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/cei.12202","article-title":"Molecular diagnosis of chronic granulomatous disease","volume":"175","author":"Roos","year":"2014","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.coi.2021.07.001_bib0215","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.hoc.2012.11.002","article-title":"Chronic granulomatous disease","volume":"27","author":"Holland","year":"2013","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.coi.2021.07.001_bib0220","doi-asserted-by":"crossref","first-page":"3957","DOI":"10.1172\/JCI97116","article-title":"Inherited p40(phox) deficiency differs from classic chronic granulomatous disease","volume":"128","author":"van de Geer","year":"2018","journal-title":"J Clin Invest"},{"key":"10.1016\/j.coi.2021.07.001_sbref0225","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.jaci.2018.09.019","article-title":"EROS\/CYBC1 mutations: decreased NADPH oxidase function and chronic granulomatous disease","volume":"143","author":"Thomas","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2021.07.001_bib0230","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jaci.2015.11.041","article-title":"Mycobacterial disease in patients with chronic granulomatous disease: a retrospective analysis of 71 cases","volume":"138","author":"Conti","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2021.07.001_bib0235","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s10875-020-00750-5","article-title":"Genetic, immunological, and clinical features of the first Mexican cohort of patients with chronic granulomatous disease","volume":"40","author":"Blancas-Galicia","year":"2020","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.coi.2021.07.001_bib0240","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/s10875-018-0486-y","article-title":"A cohort of 169 chronic granulomatous disease patients exposed to BCG vaccination: a retrospective study from a single center in Shanghai, China (2004-2017)","volume":"38","author":"Zhou","year":"2018","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.coi.2021.07.001_bib0245","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/INF.0b013e31815b494c","article-title":"Susceptibility to mycobacterial infections in children with X-linked chronic granulomatous disease: a review of 17 patients living in a region endemic for tuberculosis","volume":"27","author":"Lee","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.coi.2021.07.001_bib0250","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/ni.1992","article-title":"Germline CYBB mutations that selectively affect macrophages in kindreds with X-linked predisposition to tuberculous mycobacterial disease","volume":"12","author":"Bustamante","year":"2011","journal-title":"Nat Immunol"},{"key":"10.1016\/j.coi.2021.07.001_bib0255","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/bjh.13317","article-title":"Haematopoietic and immune defects associated with GATA2 mutation","volume":"169","author":"Collin","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1016\/j.coi.2021.07.001_bib0260","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1182\/blood-2011-05-356352","article-title":"Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome","volume":"118","author":"Hsu","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.coi.2021.07.001_bib0265","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/ng.949","article-title":"GATA2 mutations lead to MDS and AML","volume":"43","author":"Hyde","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.coi.2021.07.001_bib0270","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/ng.923","article-title":"Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome)","volume":"43","author":"Ostergaard","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.coi.2021.07.001_bib0275","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1182\/blood-2011-06-360313","article-title":"Exome sequencing identifies GATA-2 mutation as the cause of dendritic cell, monocyte, B and NK lymphoid deficiency","volume":"118","author":"Dickinson","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.coi.2021.07.001_sbref0280","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s10875-020-00930-3","article-title":"Inherited GATA2 deficiency is dominant by haploinsufficiency and displays incomplete clinical penetrance","volume":"41","author":"Oleaga-Quintas","year":"2021","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.coi.2021.07.001_bib0285","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.smim.2014.09.008","article-title":"Mendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-gamma immunity","volume":"26","author":"Bustamante","year":"2014","journal-title":"Semin Immunol"},{"key":"10.1016\/j.coi.2021.07.001_bib0290","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/j.jaci.2018.10.068","article-title":"IFN-gamma and CD25 drive distinct pathologic features during hemophagocytic lymphohistiocytosis","volume":"143","author":"Humblet-Baron","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2021.07.001_sbref0295","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1016\/j.cell.2020.10.046","article-title":"Human T-bet governs both innate and innate-like adaptive IFN-\u03b3 immunity against mycobacteria","volume":"183","author":"Yang","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.coi.2021.07.001_sbref0300","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1172\/JCI135460","article-title":"Inherited human IFN-gamma deficiency underlies mycobacterial disease","volume":"130","author":"Kerner","year":"2020","journal-title":"J Clin Invest"},{"key":"10.1016\/j.coi.2021.07.001_bib0305","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aau6759","article-title":"Human IFN-gamma immunity to mycobacteria is governed by both IL-12 and IL-23","volume":"3","author":"Martinez-Barricarte","year":"2018","journal-title":"Sci Immunol"},{"key":"10.1016\/j.coi.2021.07.001_sbref0310","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aau8714","article-title":"Tuberculosis and impaired IL-23-dependent IFN-gamma immunity in humans homozygous for a common TYK2 missense variant","volume":"3","author":"Boisson-Dupuis","year":"2018","journal-title":"Sci Immunol"},{"key":"10.1016\/j.coi.2021.07.001_bib0315","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/imcb.12210","article-title":"Mendelian susceptibility to mycobacterial disease: 2014-2018 update","volume":"97","author":"Rosain","year":"2018","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.coi.2021.07.001_sbref0320","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/s41590-018-0178-z","article-title":"Disruption of an antimycobacterial circuit between dendritic and helper T cells in human SPPL2a deficiency","volume":"19","author":"Kong","year":"2018","journal-title":"Nat Immunol"},{"key":"10.1016\/j.coi.2021.07.001_bib0325","first-page":"3919","article-title":"A purely quantitative form of partial recessive IFN-gamma R2 deficiency caused by mutations of the initiation or second codon","volume":"27","author":"Oleaga-Quintas","year":"2018","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.coi.2021.07.001_bib0330","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1034\/j.1600-065X.2000.17810.x","article-title":"Human interferon-gamma-mediated immunity is a genetically controlled continuous trait that determines the outcome of mycobacterial invasion","volume":"178","author":"Dupuis","year":"2000","journal-title":"Immunol Rev"},{"key":"10.1016\/j.coi.2021.07.001_sbref0335","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2102804118","article-title":"Inherited deficiency of stress granule ZNFX1 in patients with monocytosis and mycobacterial disease","volume":"118","author":"Le Voyer","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coi.2021.07.001_bib0340","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1056\/NEJM199612263352604","article-title":"Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guerin infection","volume":"335","author":"Jouanguy","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coi.2021.07.001_bib0345","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1056\/NEJM199612263352602","article-title":"A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection","volume":"335","author":"Newport","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coi.2021.07.001_bib0350","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1126\/science.aaa4282","article-title":"IMMUNODEFICIENCIES. Impairment of immunity to Candida and Mycobacterium in humans with bi-allelic RORC mutations","volume":"349","author":"Okada","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.coi.2021.07.001_bib0355","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1126\/science.1224026","article-title":"Mycobacterial disease and impaired IFN-gamma immunity in humans with inherited ISG15 deficiency","volume":"337","author":"Bogunovic","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.coi.2021.07.001_bib0360","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nature13801","article-title":"Human intracellular ISG15 prevents interferon-alpha\/beta over-amplification and auto-inflammation","volume":"517","author":"Zhang","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.coi.2021.07.001_bib0365","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms13992","article-title":"Biallelic JAK1 mutations in immunodeficient patient with mycobacterial infection","volume":"7","author":"Eletto","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.coi.2021.07.001_bib0370","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/ng1097","article-title":"Impaired response to interferon-alpha\/beta and lethal viral disease in human STAT1 deficiency","volume":"33","author":"Dupuis","year":"2003","journal-title":"Nat Genet"},{"key":"10.1016\/j.coi.2021.07.001_bib0375","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1084\/jem.20140280","article-title":"Human TYK2 deficiency: Mycobacterial and viral infections without hyper-IgE syndrome","volume":"212","author":"Kreins","year":"2015","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2021.07.001_bib0380","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0018524","article-title":"IL-12Rb1 deficiency in two of fifty children with severe tuberculosis from Iran, Morocco, and Turkey","volume":"6","author":"Boisson-Dupuis","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.coi.2021.07.001_bib0385","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1086\/375587","article-title":"Clinical tuberculosis in 2 of 3 siblings with interleukin-12 receptor beta1 deficiency","volume":"37","author":"Caragol","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.coi.2021.07.001_bib0390","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1086\/427879","article-title":"Interleukin-12 receptor beta 1 chain deficiency in a child with disseminated tuberculosis","volume":"40","author":"\u00d6zbek","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.coi.2021.07.001_bib0395","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1086\/321999","article-title":"Interleukin-12 receptor beta1 deficiency in a patient with abdominal tuberculosis","volume":"184","author":"Altare","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coi.2021.07.001_bib0400","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s10875-011-9523-9","article-title":"Lethal tuberculosis in a previously healthy adult with IL-12 receptor deficiency","volume":"31","author":"Tabarsi","year":"2011","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.coi.2021.07.001_sbref0405","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-021-01388-5","article-title":"Inherited PD-1 deficiency underlies tuberculosis and autoimmunity in a child","author":"Ogishi","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.coi.2021.07.001_sbref0410","doi-asserted-by":"crossref","first-page":"10430","DOI":"10.1073\/pnas.1903561116","article-title":"Homozygosity for TYK2 P1104A underlies tuberculosis in about 1% of patients in a cohort of European ancestry","volume":"116","author":"Kerner","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coi.2021.07.001_bib0415","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.ajhg.2021.02.009","article-title":"Human ancient DNA analyses reveal the high burden of tuberculosis in Europeans over the last 2,000 years","volume":"108","author":"Kerner","year":"2021","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.coi.2021.07.001_bib0420","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aag1974","article-title":"Resolving TYK2 locus genotype-to-phenotype differences in autoimmunity","volume":"8","author":"Dendrou","year":"2016","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.coi.2021.07.001_bib0425","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0122271","article-title":"TYK2 protein-coding variants protect against rheumatoid arthritis and autoimmunity, with no evidence of major pleiotropic effects on non-autoimmune complex traits","volume":"10","author":"Diogo","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.coi.2021.07.001_sbref0430","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s00439-020-02180-0","article-title":"Autoantibodies against cytokines: phenocopies of primary immunodeficiencies?","volume":"139","author":"Ku","year":"2020","journal-title":"Hum Genet"},{"key":"10.1016\/j.coi.2021.07.001_bib0435","doi-asserted-by":"crossref","DOI":"10.1126\/science.abd4570","article-title":"Inborn errors of type I IFN immunity in patients with life-threatening COVID-19","volume":"370","author":"Zhang","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.coi.2021.07.001_bib0440","doi-asserted-by":"crossref","DOI":"10.1126\/science.abd4585","article-title":"Autoantibodies against type I IFNs in patients with life-threatening COVID-19","volume":"370","author":"Bastard","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.coi.2021.07.001_bib0445","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1182\/blood-2003-04-1065","article-title":"Naturally occurring anti-IFN-gamma autoantibody and severe infections with Mycobacterium cheloneae and Burkholderia cocovenenans","volume":"103","author":"Hoflich","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.coi.2021.07.001_bib0450","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1086\/380453","article-title":"Autoantibodies to interferon-gamma in a patient with selective susceptibility to mycobacterial infection and organ-specific autoimmunity","volume":"38","author":"Doffinger","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.coi.2021.07.001_bib0455","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1007\/s10875-019-00652-1","article-title":"Juvenile-onset immunodeficiency secondary to anti-interferon-gamma autoantibodies","volume":"39","author":"Liew","year":"2019","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.coi.2021.07.001_bib0460","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1172\/JCI19316","article-title":"Acquired predisposition to mycobacterial disease due to autoantibodies to IFN-gamma","volume":"115","author":"Kampmann","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.coi.2021.07.001_bib0465","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1007\/s10875-014-0073-9","article-title":"The first US domestic report of disseminated Mycobacterium avium complex and anti-interferon-gamma autoantibodies","volume":"34","author":"O\u2019Connell","year":"2014","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.coi.2021.07.001_bib0470","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1056\/NEJMoa1111160","article-title":"Adult-onset immunodeficiency in Thailand and Taiwan","volume":"367","author":"Browne","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coi.2021.07.001_sbref0475","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20190502","article-title":"Anti-IFN-gamma autoantibodies underlie disseminated Talaromyces marneffei infections","volume":"217","author":"Guo","year":"2020","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2021.07.001_bib0480","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1182\/blood-2012-08-452482","article-title":"Anti-IFN-gamma autoantibodies in adults with disseminated nontuberculous mycobacterial infections are associated with HLA-DRB1*16:02 and HLA-DQB1*05:02 and the reactivation of latent varicella-zoster virus infection","volume":"121","author":"Chi","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.coi.2021.07.001_bib0485","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.jaci.2015.09.018","article-title":"Anti-IFN-gamma autoantibodies are strongly associated with HLA-DR*15:02\/16:02 and HLA-DQ*05:01\/05:02 across Southeast Asia","volume":"137","author":"Ku","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2021.07.001_bib0490","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s15010-017-1060-x","article-title":"A 38-year-old woman with necrotising cervical lymphadenitis due to Histoplasma capsulatum","volume":"45","author":"van de Vosse","year":"2017","journal-title":"Infection"},{"key":"10.1016\/j.coi.2021.07.001_bib0495","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1542\/peds.98.4.774","article-title":"Idiopathic disseminated bacillus Calmette-Guerin infection: a French national retrospective study","volume":"98","author":"Casanova","year":"1996","journal-title":"Pediatrics"}],"container-title":["Current Opinion in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791521000881?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791521000881?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T08:50:11Z","timestamp":1760604611000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952791521000881"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":99,"alternative-id":["S0952791521000881"],"URL":"https:\/\/doi.org\/10.1016\/j.coi.2021.07.001","relation":{},"ISSN":["0952-7915"],"issn-type":[{"value":"0952-7915","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mycobacterial diseases in patients with inborn errors of immunity","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coi.2021.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}